AstraZeneca
AZN
#44
Rank
$246.95 B
Marketcap
$79.65
Share price
1.35%
Change (1 day)
18.79%
Change (1 year)

P/E ratio for AstraZeneca (AZN)

P/E ratio as of July 2024 (TTM): 39.6

According to AstraZeneca's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.5919. At the end of 2022 the company had a P/E ratio of 64.0.

P/E ratio history for AstraZeneca from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202264.0-84.08%
2021402880.4%
202041.0-57.68%
201996.8116.68%
201844.752.59%
201729.348.32%
201619.7-35.16%
201530.4-57.6%
201471.8146.77%
201329.1205.99%
20129.5150.61%
20116.32-23.44%
20108.25-8.8%
20099.04-7.42%
20089.77-14.67%
200711.4-17.47%
200613.9-16.93%
200516.72135.52%
20040.7471-97.27%
200327.327.75%
200221.4-25.68%
200128.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
10.4-73.79%๐Ÿ‡บ๐Ÿ‡ธ USA
15.9-59.94%๐Ÿ‡บ๐Ÿ‡ธ USA
68.9 73.92%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1-71.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
15.7-60.25%๐Ÿ‡ซ๐Ÿ‡ท France
173 338.04%๐Ÿ‡บ๐Ÿ‡ธ USA
10.7-72.92%๐Ÿ‡บ๐Ÿ‡ธ USA
34.6-12.71%๐Ÿ‡บ๐Ÿ‡ธ USA
12.2-69.21%๐Ÿ‡บ๐Ÿ‡ธ USA
29.6-25.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.